Tuosheng Pharma Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $40M

  • Investors
  • 10

Tuosheng Pharma General Information

Description

Manufacturer of antibody-drug conjugate therapeutics intended to support targeted and differentiated cancer treatment development. The company offers proprietary payload engineering, multi-target conjugation technologies, and integrated development capabilities, thereby enabling pharmaceutical partners and oncology treatment providers to advance safer and more effective anticancer drugs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 1201-1, Building A2, Southwest corner of the intersection of Chuangxin Avenue
  • Yulan Avenue, Feixi County Economic Development Zone
  • Hefei, Anhui
  • China
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • Room 1201-1, Building A2, Southwest corner of the intersection of Chuangxin Avenue
  • Yulan Avenue, Feixi County Economic Development Zone
  • Hefei, Anhui
  • China

Tuosheng Pharma Timeline

2026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tuosheng Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 04-Feb-2026 $40M Completed Generating Revenue
2. Early Stage VC 20-Jan-2026 Completed Generating Revenue
1. Seed Round 26-Nov-2025 Completed Startup
To view Tuosheng Pharma’s complete valuation and funding history, request access »

Tuosheng Pharma Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Betta Pharmaceuticals Corporation Minority
Hangzhou Tigermed Consulting Company Corporation Minority
Ningbo Hongning Hengtai Investment Management Venture Capital Minority
Shanghai Songjiang State-owned Assets Investment Government Minority
Shenzhen Jiadaogu Investment Management Growth/Expansion Minority
You’re viewing 5 of 10 investors. Get the full list »

Tuosheng Pharma FAQs

  • When was Tuosheng Pharma founded?

    Tuosheng Pharma was founded in 2025.

  • Where is Tuosheng Pharma headquartered?

    Tuosheng Pharma is headquartered in Hefei, China.

  • What industry is Tuosheng Pharma in?

    Tuosheng Pharma’s primary industry is Biotechnology.

  • Is Tuosheng Pharma a private or public company?

    Tuosheng Pharma is a Private company.

  • What is Tuosheng Pharma’s current revenue?

    The current revenue for Tuosheng Pharma is .

  • How much funding has Tuosheng Pharma raised over time?

    Tuosheng Pharma has raised $40M.

  • Who are Tuosheng Pharma’s investors?

    Betta Pharmaceuticals, Hangzhou Tigermed Consulting Company, Ningbo Hongning Hengtai Investment Management, Shanghai Songjiang State-owned Assets Investment, and Shenzhen Jiadaogu Investment Management are 5 of 10 investors who have invested in Tuosheng Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process